Adcock buys Cosme assets with eye on Indian free medicines plan
This article was originally published in Scrip
Executive Summary
South Africa's Adcock Ingram is acquiring certain core assets of the privately-owned Indian firm, Cosme Farma Laboratories, for about Rand778 million ($94.3 million), as part of its strategy to wedge deeper into the fast-growing Indian market. It also appears to have its eye on potential opportunities emerging from India's proposed free medicines plan.